184 results on '"A. Van Hout"'
Search Results
2. Costs of care trajectories of people with dementia compared with matched controls. Longitudinal analysis of linked health and administrative data
- Author
-
Bosmans, Judith E., primary, van der Heide, Iris, additional, van Hout, Hein P. J., additional, and Joling, Karlijn J., additional
- Published
- 2024
- Full Text
- View/download PDF
3. Exploring health preference heterogeneity in the UK: Using the online elicitation of personal utility functions approach to construct EQ‐5D‐5L value functions on societal, group and individual level
- Author
-
Schneider, Paul, primary, Devlin, Nancy, additional, van Hout, Ben, additional, and Brazier, John, additional
- Published
- 2024
- Full Text
- View/download PDF
4. The role of experiential avoidance and cognitive fusion in the development of anxiety symptoms among family carers of people with dementia
- Author
-
Van Hout, Elien, primary, Contreras, Milena L, additional, Mioshi, Eneida, additional, and Kishita, Naoko, additional
- Published
- 2023
- Full Text
- View/download PDF
5. Lessons learned from the development of a national registry on dementia care and support based on linked national health and administrative data
- Author
-
van der Heide, Iris, primary, Francke, Anneke L., additional, Döpp, Carola, additional, Heins, Marianne, additional, van Hout, Hein P. J., additional, Verheij, Robert A., additional, and Joling, Karlijn J., additional
- Published
- 2023
- Full Text
- View/download PDF
6. Oral health services in prison settings: A global scoping review of availability, accessibility, and model of delivery
- Author
-
Amaya, Arianna, primary, Medina, Ivan, additional, Mazzilli, Sara, additional, D'Arcy, Jemima, additional, Cocco, Nicola, additional, Van Hout, Marie‐Claire, additional, Stöver, Heino, additional, and Moazen, Babak, additional
- Published
- 2023
- Full Text
- View/download PDF
7. Informal caregiver and nurse perceptions of access to culturally appropriate health care for ethnic minority persons with dementia: A qualitative study
- Author
-
Duran‐Kiraç, Gözde, primary, Uysal‐Bozkir, Özgül, additional, Uittenbroek, Ronald, additional, van Hout, Hein, additional, and Broese van Groenou, Marjolein I., additional
- Published
- 2023
- Full Text
- View/download PDF
8. Neuropsychological assessment in the multicultural memory clinic: development and feasibility of the TULIPA battery
- Author
-
Franzen, Sanne, primary, van den Berg, Esther, additional, Bossenbroek, Willemijn, additional, Kranenburg, Judi, additional, Scheffers, Esther, additional, van Hout, Moniek, additional, van de Wiel, Lotte, additional, Goudsmit, Miriam, additional, van Bruchem‐Visser, Rozemarijn L., additional, van Hemmen, Judy, additional, Jiskoot, Lize C., additional, and Papma, Janne M., additional
- Published
- 2022
- Full Text
- View/download PDF
9. A call for health systems to monitor the health‐related quality of life of people living with HIV
- Author
-
Lazarus, Jeffrey V., primary, Van Hout, Marie Claire, additional, Fuster‐Ruizdeapodaca, Maria J., additional, Brown, Graham, additional, and Guaraldi, Giovanni, additional
- Published
- 2022
- Full Text
- View/download PDF
10. The burden of pathogenic variants in clinically actionable genes in a founder population
- Author
-
Elizabeth A. Streeten, Braxton D. Mitchell, Toni I. Pollin, Megan Lynch, Alan R. Shuldiner, Claudia Gonzaga-Jauregui, Kristin A. Maloney, Huichun Xu, and Cristopher V. Van Hout
- Subjects
Adult ,Male ,medicine.medical_specialty ,Population ,Genomics ,Biology ,Genetic drift ,Exome Sequencing ,Genetics ,medicine ,Humans ,Exome ,Genetic Predisposition to Disease ,Genetic Testing ,Precision Medicine ,education ,Genetics (clinical) ,Exome sequencing ,Genetic testing ,education.field_of_study ,medicine.diagnostic_test ,Genetic Diseases, Inborn ,Genetic Variation ,Middle Aged ,Old Order Amish ,Medical genetics ,Female ,Amish ,Founder effect - Abstract
Founder populations may be enriched with certain genetic variants of high clinical impact compared to nonfounder populations due to bottleneck events and genetic drift. Using exome sequencing (ES), we quantified the load of pathogenic variants that may be clinically actionable in 6136 apparently healthy adults living in the Lancaster, PA Old Order Amish settlement. We focused on variants in 78 genes deemed clinically actionable by the American College of Medical Genetics and Genomics (ACMG) or Geisinger's MyCode Health Initiative. ES revealed 3191 total variants among these genes including 480 nonsynonymous variants. After quality control and filtering, we applied the ACMG/AMP guidelines for variant interpretation and classified seven variants, across seven genes, as either pathogenic or likely pathogenic. Through genetic drift, all seven variants, are highly enriched in the Amish compared to nonfounder populations. In total, 14.7% of Lancaster Amish individuals carry at least one of these variants, largely explained by the 13% who harbor a copy of a single variant in APOB. Other studies report combined frequencies of pathogenic/likely pathogenic (P/LP) variants in actionable genes between 2.0% and 6.2% in outbred populations. The Amish population harbors fewer actionable variants compared to similarly characterized nonfounder populations but have a higher frequency of each variant identified, offering opportunities for efficient and cost-effective targeted precision medicine.
- Published
- 2021
- Full Text
- View/download PDF
11. Genome‐wide association analysis of serum alanine and aspartate aminotransferase, and the modifying effects of BMI in 388k European individuals
- Author
-
Chuan Gao, Anthony Marcketta, Joshua D. Backman, Colm O'Dushlaine, Jeffrey Staples, Manuel Allen Revez Ferreira, Luca A. Lotta, John D. Overton, Jeffrey G. Reid, Tooraj Mirshahi, null Regeneron Genetics Center, null Geisinger Regeneron Discovehr Collaboration, Aris Baras, Gonçalo Abecasis, Alan R. Shuldiner, Cristopher V. Van Hout, and Shane McCarthy
- Subjects
ALT ,Epidemiology ,interaction ,Physiology ,Genome-wide association study ,digestive system ,Body Mass Index ,03 medical and health sciences ,Liver disease ,Genome-Wide Association Analysis ,medicine ,Humans ,GWAS ,Aspartate Aminotransferases ,AST ,Research Articles ,Genetics (clinical) ,030304 developmental biology ,Genetic association ,Alanine ,0303 health sciences ,business.industry ,030305 genetics & heredity ,Alanine Transaminase ,medicine.disease ,digestive system diseases ,Genetic architecture ,Minor allele frequency ,liver disease ,business ,Body mass index ,Genome-Wide Association Study ,Research Article - Abstract
Serum alanine aminotransferase (ALT) and aspartate aminotransferase (AST) are biomarkers for liver health. Here we report the largest genome‐wide association analysis to date of serum ALT and AST levels in over 388k people of European ancestry from UK biobank and DiscovEHR. Eleven million imputed markers with a minor allele frequency (MAF) ≥ 0.5% were analyzed. Overall, 300 ALT and 336 AST independent genome‐wide significant associations were identified. Among them, 81 ALT and 61 AST associations are reported for the first time. Genome‐wide interaction study identified 9 ALT and 12 AST independent associations significantly modified by body mass index (BMI), including several previously reported potential liver disease therapeutic targets, for example, PNPLA3, HSD17B13, and MARC1. While further work is necessary to understand the effect of ALT and AST‐associated variants on liver disease, the weighted burden of significant BMI‐modified signals is significantly associated with liver disease outcomes. In summary, this study identifies genetic associations which offer an important step forward in understanding the genetic architecture of serum ALT and AST levels. Significant interactions between BMI and genetic loci not only highlight the important role of adiposity in liver damage but also shed light on the genetic etiology of liver disease in obese individuals.
- Published
- 2021
- Full Text
- View/download PDF
12. Psychotropic drug prescription rates in primary care for people with dementia from recorded diagnosis onwards
- Author
-
Hein P.J. van Hout, Anneke L. Francke, Jos W. R. Twisk, Robert A Verheij, Karlijn J. Joling, Rob J. van Marum, Bregje D. Onwuteaka-Philipsen, Maud ten Koppel, General practice, APH - Aging & Later Life, APH - Mental Health, Public and occupational health, APH - Quality of Care, Epidemiology and Data Science, APH - Health Behaviors & Chronic Diseases, APH - Methodology, APH - Digital Health, Tranzo, Scientific center for care and wellbeing, and Huisarts & Ziekenhuis
- Subjects
medicine.medical_specialty ,psychotropic drug prescriptions ,Primary care ,Drug Prescriptions ,03 medical and health sciences ,0302 clinical medicine ,medicine ,Humans ,Electronic Health Records ,Dementia ,Medical prescription ,Adverse effect ,Research Articles ,Netherlands ,Psychotropic Drugs ,Primary Health Care ,030214 geriatrics ,business.industry ,Disease trajectory ,DEMENTIA ,medicine.disease ,Psychiatry and Mental health ,Psychotropic drug ,Family medicine ,Observational study ,Geriatrics and Gerontology ,Nursing homes ,business ,Research Article - Abstract
Background:Psychotropic drugs are frequently prescribed to people with dementia in nursing homes although severe adverse events and side effects are common. Less is known about the prevalence and types of psychotropic drug prescription in primary care for people with dementia.Objective:This study examined the prevalence of psychotropic drug prescriptions in primary care among persons with dementia from the year of diagnosis onwards.Methods:A longitudinal observational study using electronic health record (EHR) data was conducted. People with dementia were selected from EHR data of 451 general practices in the Netherlands. Age and gender-adjusted psychotropic drug prescription rates were calculated per 1000 person-years from the year the dementia diagnosis was first recorded in general practice up to 8 years after diagnosis.Results:Data of 15,687 patients were analyzed. The prescription rate of psychotropic drugs (not including antidementia drugs) was 420 per 1000 person-years (95% CI 409; 431) in the first year after the recorded dementia diagnosis, which increased to 801 per 1000 person-years (95% CI 649; 989) in the eighth year. The most frequently prescribed drugs were antidepressants, antipsychotics, and antidementia drugs, followed by anxiolytics, hypnotics, and antiepileptics.Conclusions:After a dementia diagnosis is recorded in general practice, the prevalence of psychotropic drug prescriptions is substantial and increases steadily during the disease trajectory of persons with dementia. Although the (in)appropriateness of prescribing was not assessed, these insights may stimulate primary care clinicians to (re)consider their prescription policy of psychotropics for people with dementia more carefully.
- Published
- 2020
- Full Text
- View/download PDF
13. Biallelic truncating variants in the muscular A‐type lamin‐interacting protein ( MLIP ) gene cause myopathy with hyperCKemia
- Author
-
Salzer‐Sheelo, Liat, primary, Fellner, Avi, additional, Orenstein, Naama, additional, Bazak, Lily, additional, Lev‐El Halabi, Noa, additional, Daue, Melanie, additional, Smirin‐Yosef, Pola, additional, Van Hout, Cristopher V., additional, Fellig, Yakov, additional, Ruhrman‐Shahar, Noa, additional, Staples, Jeffrey, additional, Magal, Nurit, additional, Shuldiner, Alan R., additional, Mitchell, Braxton D., additional, Nevo, Yoram, additional, Pollin, Toni I., additional, Gonzaga‐Jauregui, Claudia, additional, and Basel‐Salmon, Lina, additional
- Published
- 2022
- Full Text
- View/download PDF
14. Everyday functioning in a community‐based volunteer population: Factors associated with concordance between participant and study partner—Report
- Author
-
Merike Verrijp, Mark A. Dubbelman, Leonie N.C. Visser, Roos J. Jutten, Elke W Nijhuis, Hein PJ Van Hout, Philip Scheltens, Wiesje M van der Flier, and Sietske A.M. Sikkes
- Subjects
Psychiatry and Mental health ,Cellular and Molecular Neuroscience ,Developmental Neuroscience ,Epidemiology ,Health Policy ,Neurology (clinical) ,Geriatrics and Gerontology - Published
- 2021
- Full Text
- View/download PDF
15. Examining the carer‐related and patient‐related factors predicting anxiety amongst family carers of people with dementia
- Author
-
Elien Van Hout, Milena L Contreras, Eneida Mioshi, and Naoko Kishita
- Subjects
Psychiatry and Mental health ,Cellular and Molecular Neuroscience ,Developmental Neuroscience ,Epidemiology ,Health Policy ,Neurology (clinical) ,Geriatrics and Gerontology - Published
- 2021
- Full Text
- View/download PDF
16. Accessibility of health care experienced by persons with dementia from ethnic minority groups and (in)formal caregivers: A scoping review
- Author
-
van Groenou, Marjolein Broese, Duran, Gozde, van Hout, Hein Pj, General practice, and APH - Aging & Later Life
- Subjects
Psychiatry and Mental health ,Cellular and Molecular Neuroscience ,Developmental Neuroscience ,Epidemiology ,Health Policy ,Neurology (clinical) ,Geriatrics and Gerontology - Abstract
BACKGROUND: the number of persons with dementia from ethnic minority backgrounds is increasing. However, ethnic minority groups use health care services less frequently compared to non-migrants. METHOD: We conducted a scoping review and used the theoretical framework developed by Levesque to provide an overview of the literature concerning access to health care for ethnic minority people with dementia and (in)formal caregivers. Our search strategy identified 28 empirical studies in the period 2008-2019. RESULT: Studies mentioned barriers in (1) the ability to perceive a need for care in terms of health literacy, health beliefs and trust and expectations; (2) the ability to seek care because of personal and social values and the lack of knowledge regarding health care options; (3) lack of person-centered care as barrier to continue with professional health care. Studies also mentioned barriers experienced by professionals in (1) communication with ethnic minorities and knowledge about available resources for professionals; (2) cultural and social factors influencing the professionals' attitudes towards ethnic minorities; (3) the appropriateness of care and lacking competencies to work with people with dementia from ethnic minority groups and informal caregivers. CONCLUSION: Ethnic minority people with dementia and informal caregivers may benefit from improve their abilities to access health care. Health care professionals need to strengthen their competencies in order to facilitate access to health care for this group.
- Published
- 2021
- Full Text
- View/download PDF
17. Everyday functioning in a community‐based volunteer population: Factors associated with concordance between participant and study partner—Report
- Author
-
Verrijp, Merike, primary, Dubbelman, Mark A., additional, Visser, Leonie N.C., additional, Jutten, Roos J., additional, Nijhuis, Elke W, additional, Van Hout, Hein PJ, additional, Scheltens, Philip, additional, van der Flier, Wiesje M, additional, and Sikkes, Sietske A.M., additional
- Published
- 2021
- Full Text
- View/download PDF
18. Examining the carer‐related and patient‐related factors predicting anxiety amongst family carers of people with dementia
- Author
-
Van Hout, Elien, primary, Contreras, Milena L, additional, Mioshi, Eneida, additional, and Kishita, Naoko, additional
- Published
- 2021
- Full Text
- View/download PDF
19. In search of the nation in Fiume: Irredentism, cultural nationalism, borderlands
- Author
-
Milou van Hout and ARTES (FGw)
- Subjects
Cultural nationalism ,Arts and Humanities (miscellaneous) ,Political science ,Political Science and International Relations ,Geography, Planning and Development ,General Medicine ,Irredentism ,Ancient history - Abstract
Irredentism is a crucial, yet understudied phenomenon of nationalism. Most scholars emphasise how irredentist thinking and practices function as a geopolitical instrument for inter-state formation, resulting in radical nationalism. This article sheds light instead on the cultural preoccupations underlying irredentist discourses. It focusses on irredentist claims on the Adriatic city of Fiume (Rijeka) among Italian nationalists in the 19th and 20th centuries, emphasising how they were driven by cultural imaginaries of a spiritual borderland for the nation. These imaginaries continued to inform irredentist arguments during the phase of political mobilisation. This sheds light on contemporary European politics, in which irredentist imaginaries are once again shaping nationalist discourses.
- Published
- 2019
- Full Text
- View/download PDF
20. Critical Period Claim Revisited: Reanalysis of Hartshorne, Tenenbaum, and Pinker (2018) Suggests Steady Decline and Learner‐Type Differences
- Author
-
van der Slik, Frans, primary, Schepens, Job, additional, Bongaerts, Theo, additional, and van Hout, Roeland, additional
- Published
- 2021
- Full Text
- View/download PDF
21. Carvedilol and metoprolol are both able to preserve myocardial function in type 2 diabetes
- Author
-
Jeffrey R. Erickson, Carol T. Bussey, Isabelle van Hout, Rachael R Iremonger, Gerard T. Wilkins, Regis R. Lamberts, and Aram A. Babakr
- Subjects
Male ,Cardiovascular Conditions, Disorders and Treatments ,Cardiac function curve ,medicine.medical_specialty ,Physiology ,Type 2 diabetes ,carvedilol ,030204 cardiovascular system & hematology ,lcsh:Physiology ,β‐blocker ,Contractility ,03 medical and health sciences ,0302 clinical medicine ,Physiology (medical) ,Diabetes mellitus ,Diabetic cardiomyopathy ,Internal medicine ,medicine ,Animals ,Humans ,Coronary Artery Bypass ,Carvedilol ,Aged ,Original Research ,Metoprolol ,Ejection fraction ,lcsh:QP1-981 ,business.industry ,Heart ,myocardial ,Middle Aged ,medicine.disease ,Adrenergic beta-1 Receptor Antagonists ,metoprolol ,Rats, Zucker ,Disease Models, Animal ,Treatment Outcome ,Diabetes Mellitus, Type 2 ,Cardiology ,Female ,Endocrine and Metabolic Conditons, Disorders and Treatments ,business ,030217 neurology & neurosurgery ,medicine.drug - Abstract
Purpose Increasing cohorts of patients present with diabetic cardiomyopathy, and with no targeted options, treatment often rely on generic pharmaceuticals such as β‐blockers. β‐blocker efficacy is heterogenous, with second generation β‐blocker metoprolol selectively inhibiting β1‐AR, while third generation β‐blocker carvedilol has α1‐AR inhibition, antioxidant, and anti‐apoptotic actions alongside nonselective β‐AR inhibition. These additional properties have led to the hypothesis that carvedilol may improve cardiac contractility in the diabetic heart to a greater extent than metoprolol. The present study aimed to compare the efficacy of metoprolol and carvedilol on myocardial function in animal models and cardiac tissue from patients with type 2 diabetes and preserved ejection fraction. Methods Echocardiographic examination of cardiac function and assessment of myocardial function in isolated trabeculae was carried out in patients with and without diabetes undergoing coronary artery bypass grafting (CABG) who were prescribed metoprolol or carvedilol. Equivalent measures were undertaken in Zucker Diabetic Fatty (ZDF) rats following 4 weeks treatment with metoprolol or carvedilol. Results Patients receiving carvedilol compared to metoprolol had no difference in cardiac function, and no difference was apparent in myocardial function between β‐blockers. Both β‐blockers similarly improved myocardial function in diabetic ZDF rats treated for 4 weeks, without significantly affecting in vivo cardiac function. Conclusions Metoprolol and carvedilol were found to have no effect on cardiac function in type 2 diabetes with preserved ejection fraction, and were similarly effective in preventing myocardial dysfunction in ZDF rats., In this manuscript, we present data comparing the effects of carvedilol and metoprolol on in vivo and in vitro cardiac function in both diabetic and non‐diabetic human patients, as well as in a rat model of type 2 diabetes (Zucker Diabetic Fatty rats). Our data demonstrate that both carvedilol and metoprolol are able to improve the contractility of cardiac muscle from diabetic humans and rats, as well as preserving cardiac function in both models. Importantly, we saw no extra improvement in individuals or animals that received carvedilol over those who received metoprolol, suggesting that any improvement in health outcomes provided by carvedilol (as seen in the COMET study) are not derived from differences in the contractile function of the cardiac muscle.
- Published
- 2020
- Full Text
- View/download PDF
22. An exploration of the non-iterative time trade-off method to value health states
- Author
-
Aki Tsuchiya, Arne Risa Hole, Ben van Hout, Milad Karimi, and Yan Feng
- Subjects
Adult ,Male ,Time Factors ,Health Status ,Value (computer science) ,Discrete choice experiment ,Logistic regression ,Choice Behavior ,Time-trade-off ,03 medical and health sciences ,0302 clinical medicine ,Bias ,states worse than dead ,Surveys and Questionnaires ,general public health state preferences ,Statistics ,Range (statistics) ,Humans ,030212 general & internal medicine ,Research Articles ,Mathematics ,Internet ,Models, Statistical ,iteration bias ,exhaustion of lead time ,030503 health policy & services ,Health Policy ,Health states ,Female ,online survey ,Pairwise comparison ,0305 other medical science ,Research Article - Abstract
Time Trade‐Off (TTO) usually relies on “iteration,” which is susceptible to bias. Discrete Choice Experiment with duration (or DCETTO) is free of such bias, but respondents find this cognitively more challenging. This paper explores non‐iterative TTO with or without lead time: NI(LT)TTO. In NI(LT)TTO, respondents see a series of independent pairwise choices without iteration (similar to DCETTO), but one of the two scenarios always involves full health for a shorter duration (similar to TTO). We compare three different “types” of NI(LT)TTO relative to DCETTO. Each type is presented in two “modes”: (a) verbally tabulated (as in a DCE) and (b) with visual aids (as in a TTO). The study has 8 survey variants, each with 12 experimental choice tasks and a 13th task with a logically determined answer. Data on the 12 experimental choices from an online survey of 6,618 respondents are modelled, by variant, using conditional logistic regressions. The results indicate that NI(LT)TTO is feasible, but some relatively mild states appear to have implausibly low predicted values, and the range of predicted values is much narrower than in DCETTO. The presentation of NI(LT)TTO tasks needs further improvement.
- Published
- 2018
- Full Text
- View/download PDF
23. Transfusion reactions after transfusion of platelets stored in PAS-B, PAS-C, or plasma: a nationwide comparison
- Author
-
Fabienne M.A. van Hout, Johanna C. Wiersum-Osselton, Jean-Louis H. Kerkhoffs, Rutger A. Middelburg, Johanna G. van der Bom, Pieter F. van der Meer, and Martin R. Schipperus
- Subjects
medicine.medical_specialty ,Hemovigilance ,business.industry ,Immunology ,Retrospective cohort study ,Conclusive evidence ,Hematology ,Odds ratio ,030204 cardiovascular system & hematology ,Lung injury ,Confidence interval ,03 medical and health sciences ,0302 clinical medicine ,Internal medicine ,Relative risk ,medicine ,Immunology and Allergy ,Platelet ,business ,030215 immunology - Abstract
Background Platelets (PLTs) stored in PLT additive solution (PAS) are associated with fewer allergic reactions than plasma-stored PLTs. However, earlier studies could not provide conclusive evidence on febrile reactions and did not analyze other transfusion reactions separately due to limited sample size. We therefore compared incidences of all transfusion reactions of PAS-B-PLTs, PAS-C-PLTs, and plasma-PLTs. Study design and methods In this observational study, all transfusion reactions reported to the national hemovigilance office of the Netherlands from 2006 to 2015 were included. Results During the study period, a total of 2407 transfusion reactions after PLT transfusions were reported. In that period 553,267 pooled buffy coat-derived PLT units were issued, of which 83,884 were stored in PAS-B, 45,728 in PAS-C, and 423,655 in plasma. Regarding transfusion-related circulatory overload, transfusion-related acute lung injury, and "other reactions" no significant differences were observed between the PLT products. When PAS-B-PLT transfusions were compared to plasma-PLT transfusions, the overall relative risk (RR; 95% confidence interval [CI]) of transfusion reactions was 0.99 (0.88-1.11); for allergic and febrile nonhemolytic transfusion reactions (FNHTRs) it was 0.66 (0.55-0.80) and 1.54 (1.27-1.86), respectively. When PAS-C-PLTs were compared to plasma-PLTs, the RR (95% CI) was 0.56 (0.46-0.68) for all transfusion reactions, 0.38 (0.28-0.52) for allergic reactions, and 0.82 (0.59-1.13) for FNHTRs. When PAS-C-PLTs were compared to PAS-B-PLTs, for all reactions the RR (95% CI) was 0.56 (0.45-0.70) for allergic reactions 0.58 (0.40-0.82), and for FNHTRs 0.53 (0.37-0.75). Conclusions PAS-C-PLTs are associated with fewer transfusion reactions compared to plasma-PLTs and compared to PAS-B-PLTs.
- Published
- 2018
- Full Text
- View/download PDF
24. The Cognitive Online Self‐Test Amsterdam (COST‐A): Establishing norm scores in a community‐dwelling population
- Author
-
Visser, Leonie N.C., primary, Dubbelman, Mark A., additional, Verrijp, Merike, additional, Wanders, Lisa, additional, Pelt, Sophie, additional, Zwan, Marissa D., additional, Thijssen, Dick H.J., additional, Wouters, Hans, additional, Sikkes, Sietske A.M., additional, van Hout, Hein P.J., additional, and van der Flier, Wiesje M., additional
- Published
- 2021
- Full Text
- View/download PDF
25. Study partner‐ and self‐reported difficulties in cognitively complex everyday activities in participants without objective cognitive impairment
- Author
-
Verrijp, Merike, primary, Dubbelman, Mark A, additional, Nijhuis, Elke W, additional, Visser, Leonie NC, additional, Zwan, Marissa D, additional, Jutten, Roos J, additional, Van Hout, Hein PJ, additional, van Der Flier, Wiesje, additional, Scheltens, Philip, additional, and Sikkes, Sietske AM, additional
- Published
- 2020
- Full Text
- View/download PDF
26. Psychotropic drug prescription rates in primary care for people with dementia from recorded diagnosis onwards
- Author
-
Joling, Karlijn J., primary, Koppel, Maud ten, additional, van Hout, Hein P.J., additional, Onwuteaka‐Philipsen, Bregje D., additional, Francke, Anneke L., additional, Verheij, Robert A., additional, Twisk, Jos W.R., additional, and van Marum, Rob J., additional
- Published
- 2020
- Full Text
- View/download PDF
27. Dihydrocodeine for detoxification and maintenance treatment in individuals with opiate use disorders
- Author
-
Carney, Tara, primary, Van Hout, Marie Claire, additional, Norman, Ian, additional, Dada, Siphokazi, additional, Siegfried, Nandi, additional, and Parry, Charles DH, additional
- Published
- 2020
- Full Text
- View/download PDF
28. New methods for modelling EQ-5D-5L value sets: An application to English data
- Author
-
Brendan Mulhern, Koonal Shah, Ben van Hout, Nancy Devlin, and Yan Feng
- Subjects
Male ,Heteroscedasticity ,EQ‐5D‐5L ,Computer science ,Health Status ,Bayesian probability ,Choice Behavior ,Time-trade-off ,03 medical and health sciences ,0302 clinical medicine ,EQ-5D ,Surveys and Questionnaires ,Value set ,Statistics ,Econometrics ,Humans ,health utilities ,030212 general & internal medicine ,Research Articles ,Valuation (finance) ,health‐related quality of life ,Estimation theory ,030503 health policy & services ,Health Policy ,econometric modelling ,Deviance information criterion ,value set ,England ,Health Policy & Services ,Quality of Life ,Quality-Adjusted Life Years ,0305 other medical science ,Models, Econometric ,Research Article - Abstract
© 2017 The Authors Health Economics Published by John Wiley & Sons Ltd. Value sets for the EQ-5D-5L are required to facilitate its use in estimating quality-adjusted life years. An international protocol has been developed to guide the collection of stated preference data for this purpose and has been used to generate EQ-5D-5L valuation data for England. The aim of this paper is report the innovative methods used for modelling those data to obtain a value set. Nine hundred and ninety-six members of the English general public completed time trade-off (TTO) and discrete choice experiment (DCE) tasks. We estimate models, with and without interactions, using DCE data only, TTO data only, and TTO/DCE data combined. TTO data are interpreted as both left and right censored. Heteroskedasticity and preference heterogeneity between individuals are accounted for. We use Bayesian methods in the econometric analysis. The final model is chosen based on the deviance information criterion (DIC). Censoring and taking account of heteroskedasticity have important effects on parameter estimation. For DCE data only, TTO data only, and DCE/TTO data combined, models with parameters for all dimensions and levels perform best, as judged by the DIC. Taking account of heterogeneity improves fit, and the multinomial model reports the lowest DIC. This paper presents approaches that suit observed characteristics of EQ-5D-5L valuation data and recognise respondents' preference heterogeneity. The methods described are potentially relevant to other value set studies.
- Published
- 2017
- Full Text
- View/download PDF
29. Comparing transfusion reaction rates for various plasma types: a systematic review and meta-analysis/regression
- Author
-
Martin R. Schipperus, Nicholas H. Saadah, Johanna C. Wiersum-Osselton, Fabienne M.A. van Hout, Saskia le Cessie, Rutger A. Middelburg, and Johanna G. van der Bom
- Subjects
Pediatrics ,medicine.medical_specialty ,business.industry ,Immunology ,Anaphylactic reactions ,Hematology ,030204 cardiovascular system & hematology ,Lung injury ,Confidence interval ,03 medical and health sciences ,0302 clinical medicine ,Transfusion reaction ,Sex factors ,Meta-analysis ,Anesthesia ,Plasma chemistry ,medicine ,Immunology and Allergy ,030212 general & internal medicine ,business - Abstract
BACKGROUND We estimated rates for common plasma-associated transfusion reactions and compared reported rates for various plasma types. STUDY DESIGN AND METHODS We performed a systematic review and meta-analysis of peer-reviewed articles that reported plasma transfusion reaction rates. Random-effects pooled rates were calculated and compared between plasma types. Meta-regression was used to compare various plasma types with regard to their reported plasma transfusion reaction rates. RESULTS Forty-eight studies reported transfusion reaction rates for fresh-frozen plasma (FFP; mixed-sex and male-only), amotosalen INTERCEPT FFP, methylene blue-treated FFP, and solvent/detergent-treated pooled plasma. Random-effects pooled average rates for FFP were: allergic reactions, 92/105 units transfused (95% confidence interval [CI], 46-184/105 units transfused); febrile nonhemolytic transfusion reactions (FNHTRs), 12/105 units transfused (95% CI, 7-22/105 units transfused); transfusion-associated circulatory overload (TACO), 6/105 units transfused (95% CI, 1-30/105 units transfused); transfusion-related acute lung injury (TRALI), 1.8/105 units transfused (95% CI, 1.2-2.7/105 units transfused); and anaphylactic reactions, 0.8/105 units transfused (95% CI, 0-45.7/105 units transfused). Risk differences between plasma types were not significant for allergic reactions, TACO, or anaphylactic reactions. Methylene blue-treated FFP led to fewer FNHTRs than FFP (risk difference = −15.3 FNHTRs/105 units transfused; 95% CI, −24.7 to −7.1 reactions/105 units transfused); and male-only FFP led to fewer cases of TRALI than mixed-sex FFP (risk difference = −0.74 TRALI/105 units transfused; 95% CI, −2.42 to −0.42 injuries/105 units transfused). CONCLUSION Meta-regression demonstrates that the rate of FNHTRs is lower for methylene blue-treated compared with FFP, and the rate of TRALI is lower for male-only than for mixed-sex FFP; whereas no significant differences are observed between plasma types for allergic reactions, TACO, or anaphylactic reactions. Reported transfusion reaction rates suffer from high heterogeneity.
- Published
- 2017
- Full Text
- View/download PDF
30. Learning in Psychotherapy Group Supervision: Transcending Complementarity and the Generative Potential of Group Conflict
- Author
-
Paula Collens and Francie Van Hout
- Subjects
050103 clinical psychology ,Psychotherapist ,05 social sciences ,Group conflict ,Interpersonal communication ,050108 psychoanalysis ,Psychodynamics ,Complementarity (physics) ,Interconnectedness ,Psychiatry and Mental health ,Clinical Psychology ,Empirical research ,Situated ,0501 psychology and cognitive sciences ,Psychology ,Social psychology ,Generative grammar - Abstract
At the site of interpersonal conflict resides the potential for learning. This paper presents psychodynamic theories, empirical research and a fictional case study of psychotherapy group supervision. Supervision is discussed in terms of teaching and learning, triangular relations, and group and organizational perspectives. We examine the interconnectedness of patterns of distress that emerge within dynamic relational systems at the levels of the macro-social, organizational, group and individual. The concepts of equivalence, parallel process and reflection process provide frameworks for this discussion. We explore the constraints and dynamic influence of the organization upon the supervision relationship and the ethical tensions that construct im/possible positions for the supervisor. The case study tells a fictional story of a supervision group situated in an organizational context – a university psychotherapy education programme. A collapse of the group into complementarity, that is into polarized conflicted positions, proffers a vitalizing opportunity for learning. Through the clinical discussion, we reveal how this is contingent on the group's capacity to think together about the meaning of their struggle and to transcend a binary conflict and achieve ‘the third’.
- Published
- 2017
- Full Text
- View/download PDF
31. The occurrence and persistence of thoughts of suicide, self-harm and death in family caregivers of people with dementia: a longitudinal data analysis over 2 years
- Author
-
Cees M.P.M. Hertogh, Karlijn J. Joling, Siobhan O'Dwyer, and Hein P.J. van Hout
- Subjects
medicine.medical_specialty ,030214 geriatrics ,Family caregivers ,Family support ,Psychological intervention ,Poison control ,Loneliness ,medicine.disease ,Suicide prevention ,03 medical and health sciences ,Psychiatry and Mental health ,0302 clinical medicine ,medicine ,Dementia ,030212 general & internal medicine ,Geriatrics and Gerontology ,medicine.symptom ,Psychiatry ,Psychology ,Geriatric psychiatry ,Clinical psychology - Abstract
Objective Family caregivers of people with dementia often report high levels of stress and depression, but little is known about those who contemplate suicide or self-harm. This study explores thoughts of suicide, self-harm and death in dementia caregivers and investigates the characteristics that distinguish them from those without such thoughts. Methods Data were collected every 3 months, for 24 months, from 192 family caregivers of people with dementia living in the Netherlands. Caregivers did not have a clinical depression or anxiety disorder at baseline. Suicide-related thoughts were measured with an item from the Mini International Neuropsychiatric Interview, a diagnostic instrument for DSM-IV mental disorders. Fisher exact, analysis of variance or Kruskal–Wallis tests compared the characteristics of caregivers who had contemplated suicide with two comparison groups. Results Within 24 months, 76 caregivers reported symptoms of a potential depression and were further assessed for suicidal thoughts. Nine carers (11.8%, 4.7% of the total sample) reported suicidal thoughts with three of those at multiple points. Caregivers with suicidal thoughts had more severe depressive and anxious symptoms, had a lower sense of competence and mastery, felt less happy and experienced more health problems, less family support and more feelings of loneliness than caregivers who had not. Conclusion Suicidal thoughts are present in dementia caregivers and can persist across the care trajectory. Various psychological and social characteristics significantly distinguish caregivers with suicidal thoughts from those without. More research is needed to enable the identification of high-risk caregivers and provide an evidence base for the development of preventive strategies and interventions. © 2017 The Authors. International Journal of Geriatric Psychiatry Published by John Wiley & Sons Ltd.
- Published
- 2017
- Full Text
- View/download PDF
32. O5‐09‐02: DURATION OF DEMENTIA AND FORMAL CARE USE: EFFECTS OF AGE, GENDER, LIVING SITUATION, DEMENTIA MEDICATION AND ETHNICITY
- Author
-
Olin Janssen, Lisa Vermunt, Karlijn J. Joling, Frans R.J. Verhey, Ron Handels, Pieter Jelle Visser, Anneke L. Francke, Robert A Verheij, Hein P.J. van Hout, and Stephanie J.B. Vos
- Subjects
Gerontology ,Epidemiology ,business.industry ,Health Policy ,Ethnic group ,Living situation ,medicine.disease ,Psychiatry and Mental health ,Cellular and Molecular Neuroscience ,Developmental Neuroscience ,medicine ,Dementia ,Neurology (clinical) ,Geriatrics and Gerontology ,Duration (project management) ,business - Published
- 2019
- Full Text
- View/download PDF
33. Cost‐Effectiveness of<scp>LDL</scp>‐C Lowering With Evolocumab in Patients With High Cardiovascular Risk in the United States
- Author
-
Shravanthi R. Gandra, Peter Lindgren, Guillermo Villa, Ransi Somaratne, Gregg C. Fonarow, M Lothgren, and Ben van Hout
- Subjects
Male ,Time Factors ,Cost effectiveness ,Cost-Benefit Analysis ,Familial hypercholesterolemia ,030204 cardiovascular system & hematology ,law.invention ,0302 clinical medicine ,Randomized controlled trial ,Recurrence ,Risk Factors ,law ,030212 general & internal medicine ,Randomized Controlled Trials as Topic ,education.field_of_study ,Quality and Outcomes ,Anticholesteremic Agents ,Antibodies, Monoclonal ,General Medicine ,Middle Aged ,Markov Chains ,Models, Economic ,Treatment Outcome ,Cardiovascular Diseases ,Cardiology ,Drug Therapy, Combination ,Female ,Quality-Adjusted Life Years ,Erratum ,Cardiology and Cardiovascular Medicine ,medicine.medical_specialty ,Statin ,medicine.drug_class ,Population ,Down-Regulation ,Antibodies, Monoclonal, Humanized ,Drug Costs ,03 medical and health sciences ,Internal medicine ,medicine ,Humans ,Risk factor ,education ,Dyslipidemias ,business.industry ,Cholesterol, LDL ,medicine.disease ,United States ,Quality-adjusted life year ,Evolocumab ,Clinical Trials, Phase III as Topic ,business ,Biomarkers - Abstract
Randomized trials have shown marked reductions in low‐density lipoprotein cholesterol (LDL‐C), a risk factor for cardiovascular disease (CVD), when evolocumab is administered. We hypothesized that evolocumab added to standard of care (SOC) vs SOC alone is cost‐effective in the treatment of patients with heterozygous familial hypercholesterolemia (HeFH) or atherosclerotic CVD (ASCVD) with or without statin intolerance and LDL‐C >100 mg/dL. Using a Markov cohort state transition model, primary and recurrent CVD event rates were predicted considering population‐specific trial‐based mean risk factors and calibrated against observed rates in the real world. The LDL‐C–lowering effect from population‐specific phase 3 randomized studies for evolocumab was used together with estimated LDL‐C–lowering effect on CVD event rates per 38.67‐mg/dL LDL‐C lowering from a statin‐trial meta‐analysis. Costs and utilities were included from published sources. Evolocumab treatment was associated with both increased cost and improved quality‐adjusted life‐years (QALY): HeFH (incremental cost: US$153 289, incremental QALY: 2.02, incremental cost‐effectiveness ratio: US$75 863/QALY); ASCVD (US$158 307, 1.12, US$141 699/QALY); and ASCVD with statin intolerance (US$136 903, 1.36, US$100 309/QALY). Evolocumab met both the American College of Cardiology/American Heart Association (ACC/AHA) and World Health Organization (WHO) thresholds in each population evaluated. Sensitivity and scenario analyses confirmed that model results were robust to changes in model parameters. Among patients with HeFH and ASCVD with or without statin intolerance, evolocumab added to SOC may provide a cost‐effective treatment option for lowering LDL‐C using ACC/AHA intermediate/high value and WHO cost‐effectiveness thresholds. More definitive information on the clinical and economic value of evolocumab will be available from the forthcoming CVD outcomes study.
- Published
- 2016
- Full Text
- View/download PDF
34. Challenges in investigating patients with isolated decreased serum IgM: The SIMcal study
- Author
-
Janssen, Lisanne M A, van Hout, Roeland W N M, de Vries, Esther, Pignata, C, Cirillo, E, Arkwright, P D, Lougaris, V, Buckland, M, Garcia-Prat, M, d'Hebron, V, Soler-Palacin, P, Ouederni, M, Kralickova, P, Abolhassani, H, Hammerstrom, L, Aghamohamamdi, A, Santos-Pérez, J L, Sobh A, van de Werff Ten Bosch, J, Henriet, S, Kilic, S S, Karali, Y, Gonzalez-Granado, L I, Sediva, A, Huisarts & Ziekenhuis, Tranzo, Scientific center for care and wellbeing, Janssen, Lisanne M A, van Hout, Roeland W N M, de Vries, Esther, Pignata, C, Cirillo, E, Arkwright, P D, Lougaris, V, Buckland, M, Garcia-Prat, M, D'Hebron, V, Soler-Palacin, P, Ouederni, M, Kralickova, P, Abolhassani, H, Hammerstrom, L, Aghamohamamdi, A, Santos-Pérez, J L, Sobh, A, van de Werff Ten, Bosch, J, Henriet, S, Kilic, S S, Karali, Y, Gonzalez-Granado, L I, and Sediva, A
- Subjects
Male ,0301 basic medicine ,Pediatrics ,unclassified antibody deficiency ,lnfectious Diseases and Global Health Radboud Institute for Molecular Life Sciences [Radboudumc 4] ,Immunologic Deficiency Syndromes/blood ,Human Immunology ,0302 clinical medicine ,Decreased serum IgM ,T-Lymphocyte Subsets ,Young adult ,Child ,Respiratory Tract Infections ,IgM deficiency ,biology ,primary selective IgM deficiency ,General Medicine ,Middle Aged ,Child, Preschool ,Cohort ,Variation and Distance ,Female ,medicine.symptom ,Antibody ,B-Lymphocyte Subsets/cytology ,Adult ,medicine.medical_specialty ,Adolescent ,Asymptomatic Diseases/epidemiology ,Immunology ,B-Lymphocyte Subsets ,Respiratory Tract Infections/epidemiology ,primary immunodeficiency ,Asymptomatic ,Young Adult ,03 medical and health sciences ,All institutes and research themes of the Radboud University Medical Center ,medicine ,Humans ,In patient ,Preschool ,business.industry ,Immunologic Deficiency Syndromes ,Infant, Newborn ,Infant ,Newborn ,Immunoglobulin M/blood ,medicine.disease ,Language & Communication ,T-Lymphocyte Subsets/cytology ,030104 developmental biology ,Immunoglobulin M ,Asymptomatic Diseases ,Primary immunodeficiency ,biology.protein ,business ,030215 immunology - Abstract
The clinical consequences of isolated decreased serum immunoglobulin (Ig)M are not sufficiently known. Therefore, it is difficult to determine the clinical policy following such a finding. Only few reported IgM‐deficient patients fulfil the European Society for Immunodeficiencies (ESID) diagnostic criteria for selective IgM deficiency (true sIgMdef), or their diagnosis is uncertain due to insufficient laboratory data (possible sIgMdef). Decreased serum IgM is often incidentally found in asymptomatic adults. The objective of our study was to further characterize true sIgMdef and to compare the European data collected through the ESID Registry community (tertiary centres) to our previously published Dutch cohort (secondary centre). Fifteen centres (12 countries) participated with 98 patients. Patients were excluded if serum IgM was only determined once (n = 14), had normalized (n = 8), or if they also had other immunological abnormalities (n = 15). Ten patients (5 adults) completely fulfilled the ESID criteria for true sIgMdef. Age‐matched cut‐off values varied widely between centres; when using the ESID diagnostic protocol reference values, only six patients (five adults) had true sIgMdef. Because of these small numbers, further analyses were performed in patients with true or possible sIgMdef (13 adults, 48 children). Respiratory infections were commonly reported at presentation (adults 54%, children 60%). Symptomatic adults had lower serum IgM levels (mean 0.27 g/L, 95% CI 0.22‐0.31) than those without symptoms (mean 0.33 g/L, 95% CI 0.30‐0.36; P = 0.02). To be able to explore the clinical consequences of true sIgMdef, we should fully analyse and accurately describe those patients in whom a decreased serum IgM is found.
- Published
- 2019
- Full Text
- View/download PDF
35. An exploration of the non-iterative time trade off method to value health states
- Author
-
Feng, Y., Hole, A., Karimi, M., Tsuchiya, A., and van Hout, B.A.
- Abstract
Time Trade-Off (TTO) usually relies on “iteration”, which is susceptible to bias. Discrete Choice Experiment with duration (or DCETTO) is free of such bias, but respondents find this cognitively more challenging. This paper explores non-iterative TTO with or without lead time: NI(LT)TTO. In NI(LT)TTO respondents see a series of independent pairwise choices without iteration (similar to DCETTO), but one of the two scenarios always involves full health for a shorter duration (similar to TTO). We compare three different “Types” of NI(LT)TTO relative to DCETTO. Each Type is presented in two “Modes”: (a) verbally tabulated (as in a DCE); and (b) with visual aids (as in a TTO). The study has eight survey variants, each with 12 experimental choice tasks and a 13th task with a logically determined answer. Data on the 12 experimental choices from an online survey of 6,618 respondents are modelled, by variant, using conditional logistic regressions. The results indicate that NI(LT)TTO is feasible, but some relatively mild states appear to have implausibly low predicted values, and the range of predicted values is much narrower than in DCETTO. The presentation of NI(LT)TTO tasks needs further improvement.
- Published
- 2018
36. Treatment of clinical Brachyspira hyodysenteriae with zinc chelate in pigs: a blinded, randomised controlled trial
- Author
-
Lammers, Gerwen, primary, van Berkel, Robbert, additional, Roijackers, Daisy, additional, Vulders, Carly, additional, Brouwer-Middelesch, Henriëtte, additional, and van Hout, Jobke, additional
- Published
- 2019
- Full Text
- View/download PDF
37. O5‐09‐02: DURATION OF DEMENTIA AND FORMAL CARE USE: EFFECTS OF AGE, GENDER, LIVING SITUATION, DEMENTIA MEDICATION AND ETHNICITY
- Author
-
Janssen, Olin, primary, Joling, Karlijn, additional, Vos, Stephanie J.B., additional, Handels, Ron, additional, Vermunt, Lisa, additional, Francke, Anneke, additional, Verheij, Robert, additional, Verhey, Frans R.J., additional, Van Hout, Hein PJ., additional, and Visser, Pieter Jelle, additional
- Published
- 2019
- Full Text
- View/download PDF
38. Development of A Consumer-Relevant Lexicon for Testing Kitchen Cleansers Considering Different Product Usage Stages
- Author
-
Hye Seong Lee, Danielle van Hout, and In Ah Kim
- Subjects
Communication ,Point (typography) ,Descriptive statistics ,Computer science ,business.industry ,Process (engineering) ,media_common.quotation_subject ,Lexicon ,Sensory Systems ,Fast-moving consumer goods ,New product development ,Quality (business) ,Product (category theory) ,Marketing ,business ,Food Science ,media_common - Abstract
Determining critical attributes associated with consumer perceived benefit and choice is essential for the fast moving consumer goods industry. The goals of the present study were to develop a lexicon specific to usage process for kitchen cleansers using a novel consumer test and to test usage stage-dependency of the lexicon. Holistic usage process of kitchen cleansers was classified into purchase moment, during use and completion point. For a series of projective interviews, a semantic/language library, a collection of attributes relevant to kitchen cleansers was used as response options. Ethnographic observations/interviews were also incorporated into the consumer test to evoke consumers’ natural usage process. Comparisons of the developed lexicon revealed differences of consumers’ evaluation processes across different usage stages. At the purchase moment, attributes associated with Convenience and Functionality categories were found to be more important, whereas at completion point, attributes associated with Sensory Quality and Sentimental Consequence were more important. Practical Applications In sensory science literature, lexicon development for use in descriptive analysis of sensory characterization has been focused on the sensory attributes of various food products including appearance, taste, aroma, flavor, texture and aftertaste of foods. These are important not only for sensory characterization but also for communication between consumers and the people in industry, who are in charge of product development, quality control, marketing, etc. To improve communication with consumers on household cleaning products, the development of a lexicon describing consumers’ holistic product experiences, as well as investigation of the usage stage-dependency of the developed consumer attributes is required. This article introduces a new method to develop a lexicon representing consumer-relevant product attributes across different product usage stages for commercial kitchen cleanser trigger spray products and provides the lexicon associated with the product benefits of such products.
- Published
- 2015
- Full Text
- View/download PDF
39. Jannis Androutsopoulos (ed.). Mediatization and Sociolinguistic Change (Linguae & Litterae 36). Berlin, Germany/Boston, Massachusetts: Walter de Gruyter. 2014. 557 pp. Hb (9783110343571) €119.95
- Author
-
Tom Van Hout
- Subjects
Linguistics and Language ,Philosophy ,History and Philosophy of Science ,Sociology and Political Science ,Media studies ,Sociology ,Humanities ,Language and Linguistics - Published
- 2015
- Full Text
- View/download PDF
40. L1 and L2 Distance Effects in Learning L3 Dutch
- Author
-
Frans van der Slik, Roeland van Hout, and Job Schepens
- Subjects
060201 languages & linguistics ,Linguistics and Language ,Learnability ,First language ,Indo-European languages ,06 humanities and the arts ,Lexicon ,Language and Linguistics ,Linguistics ,Education ,Variation (linguistics) ,0602 languages and literature ,Multilingualism ,Language proficiency ,Psychology ,Set (psychology) - Abstract
Many people speak more than two languages. How do languages acquired earlier affect the learnability of additional languages? We show that linguistic distances between speakers’ first (L1) and second (L2) languages and their third (L3) language play a role. Larger distances from the L1 to the L3 and from the L2 to the L3 correlate with lower degrees of L3 learnability. The evidence comes from L3 Dutch speaking proficiency test scores obtained by candidates who speak a diverse set of L1s and L2s. Lexical and morphological distances between the L1s of the learners and Dutch explained 47.7% of the variation in proficiency scores. Lexical and morphological distances between the L2s of the learners and Dutch explained 32.4% of the variation in proficiency scores in multilingual learners. Cross-linguistic differences require language learners to bridge varying linguistic gaps between their L1 and L2 competences and the target language.
- Published
- 2015
- Full Text
- View/download PDF
41. Type I IFN-mediated synergistic activation of mouse and human DC subsets by TLR agonists
- Author
-
Annette E. Sköld, Ghaith Bakdash, Maaike A. van Hout-Kuijer, Carl G. Figdor, I. Jolanda M. de Vries, Martin Kreutz, and Yusuf Dolen
- Subjects
biology ,medicine.medical_treatment ,Immunology ,virus diseases ,hemic and immune systems ,Dendritic cell ,TLR7 ,Cell biology ,Membrane glycoproteins ,Cancer immunotherapy ,Antigen ,In vivo ,TLR3 ,medicine ,biology.protein ,Immunology and Allergy ,Interferon type I ,medicine.drug - Abstract
Novel approaches of dendritic cell (DC) based cancer immunotherapy aim at harnessing the unique attributes of different DC subsets. Classical monocyte-derived DC vaccines are currently being replaced by either applying primary DCs or specifically targeting antigens and adjuvants to these subsets in vivo. Appropriate DC activation in both strategies is essential for optimal effect. For this purpose TLR agonists are favorable adjuvant choices, with TLR7 triggering being essential for inducing strong Th1 responses. However, mouse CD8α(+) DCs, considered to be the major cross-presenting subset, lack TLR7 expression. Interestingly, this DC subset can respond to TLR7 ligand upon concurrent TLR3 triggering. Nevertheless, the mechanism underlying this synergy remains obscure. We now show that TLR3 ligation results in the production of IFN-α, which rapidly induces the expression of TLR7, resulting in synergistic activation. Moreover, we demonstrate that this mechanism conversely holds for plasmacytoid DCs that respond to TLR3 ligation when TLR7 pathway is mobilized. We further demonstrate that this mechanism of sharpening DC senses is also conserved in human BDCA1(+) DCs and plasmacytoid DCs. These findings have important implications for future clinical trials as it suggests that combinations of TLR ligands should be applied irrespective of initial TLR expression profiles on natural DC subsets for optimal stimulation.
- Published
- 2015
- Full Text
- View/download PDF
42. Cardiac stem cell treatment in myocardial infarction: protocol for a systematic review and meta‐analysis of preclinical studies
- Author
-
Peter-Paul Zwetsloot, Joost P.G. Sluijter, Anna M. D. Végh, Steven A. J. Chamuleau, G. P. J. van Hout, Gillian L. Currie, and Marie-José Goumans
- Subjects
Protocol (science) ,medicine.medical_specialty ,business.industry ,Bioinformatics ,medicine.disease ,Clinical trial ,Cardiac Stem Cell ,Internal medicine ,Meta-analysis ,medicine ,Cardiology ,Animal studies ,Myocardial infarction ,Stem cell ,Progenitor cell ,business - Abstract
Cardiac-derived stem or progenitor cells (CSCs) have emerged as a possible therapeutic intervention for myocardial infarction, potentially ameliorating the devastating effects caused by inadequate blood flow to the heart. The first human clinical trials using these myocardial-derived cells have recently started, but scientific controversy exists regarding the efficacy and origin of some of these stem cells in preclinical animal models. Systematic review of the current literature on CSCs in ischaemic cardiomyopathy can provide useful additional information on the use of CSCs in preclinical trials. By combining all available data, we can adequately compare the different types of cells being used and possibly identify factors that influence cardiac stem cell therapy in general. This protocol provides a thorough description of the methodology that will be used in our systematic review and meta-analysis of all preclinical animal studies involving cardiac stem cell treatment for ischaemic cardiomyopathy.
- Published
- 2015
- Full Text
- View/download PDF
43. Valuing health-related quality of life: An EQ-5D-5L value set for England
- Author
-
Devlin, NJ, Shah, KK, Feng, Y, Mulhern, B, van Hout, B, Devlin, NJ, Shah, KK, Feng, Y, Mulhern, B, and van Hout, B
- Abstract
A new version of the EQ-5D, the EQ-5D-5L, is available. The aim of this study is to produce a value set to support use of EQ-5D-5L data in decision-making. The study design followed an international research protocol. Randomly selected members of the English general public completed 10 time trade-off and 7 discrete choice experiment tasks in face-to-face interviews. A 20-parameter hybrid model was used to combine time trade-off and discrete choice experiment data to generate values for the 3,125 EQ-5D-5L health states. Valuation data are available for 996 respondents. Face validity of the data has been demonstrated, with more severe health states generally given lower values. Problems with pain/discomfort and anxiety/depression received the greatest weight. Compared to the existing EQ-5D-3L value set, there are considerably fewer "worse than dead" states (5.1%, compared with over one third), and the minimum value is higher. Values range from -0.285 (extreme problems on all dimensions) to 0.950 (for health states 11211 and 21111). Results have important implications for users of the EQ-5D-5L both in England and internationally. Quality-adjusted life year gains from interventions seeking to improve very poor health may be smaller using this value set and may previously have been overestimated.
- Published
- 2018
44. New methods for modelling EQ-5D-5L value sets: An application to English data
- Author
-
Feng, Y, Devlin, NJ, Shah, KK, Mulhern, B, van Hout, B, Feng, Y, Devlin, NJ, Shah, KK, Mulhern, B, and van Hout, B
- Abstract
Value sets for the EQ-5D-5L are required to facilitate its use in estimating quality-adjusted life years. An international protocol has been developed to guide the collection of stated preference data for this purpose and has been used to generate EQ-5D-5L valuation data for England. The aim of this paper is report the innovative methods used for modelling those data to obtain a value set. Nine hundred and ninety-six members of the English general public completed time trade-off (TTO) and discrete choice experiment (DCE) tasks. We estimate models, with and without interactions, using DCE data only, TTO data only, and TTO/DCE data combined. TTO data are interpreted as both left and right censored. Heteroskedasticity and preference heterogeneity between individuals are accounted for. We use Bayesian methods in the econometric analysis. The final model is chosen based on the deviance information criterion (DIC). Censoring and taking account of heteroskedasticity have important effects on parameter estimation. For DCE data only, TTO data only, and DCE/TTO data combined, models with parameters for all dimensions and levels perform best, as judged by the DIC. Taking account of heterogeneity improves fit, and the multinomial model reports the lowest DIC. This paper presents approaches that suit observed characteristics of EQ-5D-5L valuation data and recognise respondents' preference heterogeneity. The methods described are potentially relevant to other value set studies.
- Published
- 2018
45. Insomnia in Long-Term Care Facilities: A Comparison of Seven European Countries and Israel: The Services and Health for Elderly in Long TERm care Study
- Author
-
Jacob Gindin, A. Chetrit, Iain Carpenter, Y. Ben Israel, H Finne-Soveri, Tamar Shochat, S. Epstein, Thorsten Nikolaus, Graziano Onder, S. Levi, Roberto Bernabei, Daniela Fialová, H.P.J. van Hout, Eva Topinkova, Jean-Claude Henrard, General practice, and EMGO - Quality of care
- Subjects
Cross-Cultural Comparison ,Male ,Gerontology ,Activities of daily living ,Logistic regression ,Risk Factors ,Sleep Initiation and Maintenance Disorders ,Cultural diversity ,mental disorders ,Insomnia ,medicine ,Homes for the Aged ,Humans ,media_common.cataloged_instance ,Longitudinal Studies ,Israel ,European union ,Nursing Assessment ,Depression (differential diagnoses) ,Aged ,media_common ,Aged, 80 and over ,business.industry ,Long-Term Care ,Nursing Homes ,Europe ,Long-term care ,Cross-Sectional Studies ,Female ,Geriatrics and Gerontology ,medicine.symptom ,business ,Psychosocial - Abstract
Objectives: To assess insomnia and its correlates as part of the Services and Health for Elderly in Long TERm care (SHELTER) study, funded by the 7th Framework Programme of the European Union. Design: Cross-cultural investigation. Setting: Long-term care facilities (LTCFs) in eight European countries (Czech Republic, France, Finland, Germany, England, the Netherlands, Italy) and one non-European country (Israel). Participants: Elderly residents (N = 4,156) of 57 LTCFs. Measurements: Information on insomnia, age, sex, activities of daily living (ADLs), cognitive status, depression, major stressful life events, physical activity, fatigue, pain, and sleep medication use was extracted from the International Resident Assessment Instrument (interRAI)LTCF instrument. Rates of insomnia and its correlates were analyzed. Multivariate logistic regression was used to assess factors associated with insomnia, controlling for demographic variables. Results: The prevalence of insomnia was 24% (range 13–30%), with significant differences between countries (P < .001). More insomnia complaints were reported in older than younger residents (P < .001). Higher rates of insomnia were associated with hypnosedatives and depression in all countries (P < .001) and with stressful life events, fatigue, and pain in most countries (P < .001). No associations were found between insomnia and ADLs, physical activity, or cognitive status. Age, depression, stressful life events, fatigue, pain and hypnosedatives were independent significant predictors of insomnia, controlling for all other variables and for country. Conclusion: Hypnosedatives and depression were strong predictors of insomnia beyond cultural differences. Overall, psychosocial variables were more strongly related to insomnia than functional and mental capacities.
- Published
- 2014
- Full Text
- View/download PDF
46. Endogenous contrast MRI of cardiac fibrosis: Beyond late gadolinium enhancement
- Author
-
Joep W.M. van Oorschot, Johannes M.I.H. Gho, Gerardus P.J. van Hout, Martijn Froeling, Sanne J. Jansen of Lorkeers, Imo E. Hoefer, Pieter A. Doevendans, Peter R. Luijten, Steven A.J. Chamuleau, and Jaco J.M. Zwanenburg
- Subjects
Mri techniques ,medicine.medical_specialty ,medicine.diagnostic_test ,business.industry ,Cardiac fibrosis ,Magnetic resonance imaging ,Endogeny ,medicine.disease ,Clinical Practice ,Fibrosis ,Medicine ,Late gadolinium enhancement ,Radiology, Nuclear Medicine and imaging ,Magnetization transfer imaging ,Radiology ,business - Abstract
The aim of this review is to provide an overview of detection of cardiac fibrosis with MRI using current standards and novel endogenous MRI techniques. Assessment of cardiac fibrosis is important for diagnosis, prediction of prognosis and follow-up after therapy. During the past years, progress has been made in fibrosis detection using MRI. Cardiac infarct size can be assessed noninvasively with late gadolinium enhancement. Several methods for fibrosis detection using endogenous contrast have been developed, such as native T 1 -mapping, T 1ρ -mapping, Magnetization transfer imaging, and T 2 -mapping. Each of these methods will be described, providing the basic methodology, showing potential applications from applied studies, and discussing the potential and challenges or pitfalls. We will also identify future steps and developments that are needed for bringing these methods to the clinical practice.
- Published
- 2014
- Full Text
- View/download PDF
47. Kitchen chemistry: A scoping review of the diversionary use of pharmaceuticals for non-medicinal use and home production of drug solutions
- Author
-
Marie Claire Van Hout
- Subjects
medicine.medical_specialty ,business.industry ,Service delivery framework ,Public health ,Codeine ,Pharmaceutical Science ,Poison control ,Human factors and ergonomics ,Computer security ,computer.software_genre ,Suicide prevention ,Occupational safety and health ,Analytical Chemistry ,Nursing ,Environmental Chemistry ,Medicine ,business ,computer ,Research question ,Spectroscopy ,medicine.drug - Abstract
Misuse of pharmaceuticals is of increasing drug policy and public health concern. A scoping review was conducted on the diversionary use of pharmaceuticals for non-medicinal use and home production of drug solutions. The research question was broad: What is known from the existing literature about the diversion of pharmaceuticals for non-medicinal use and for home production of drug solutions? The scoping process centred on the systematic selection, collection, and summarization of extant knowledge within this broad thematic remit. One hundred and thirty-four records were grouped into discrete thematic categories namely: non medicinal use and tampering with pharmaceuticals, oral misuse of codeine cough syrups, homemade drug solutions, and home-produced drug-related harms in the narrative review design. Forms of abuse of codeine cough syrup include mixtures with alcohol or soft drinks ('Purple Drank'), with kratom leaves ('Kratom cocktails'), or chemically altered to extract dextromorphan ('Lemon Drop'). Production of homemade opiates ('Cheornaya', 'Kolyosa', Himiya', 'Braun', 'Krokodil'), methamphetamine ('Vint', 'Pervitin'), methcathinone ('Jeff'), and cathinone ('Boltushka') are described. Displacement patterns between the non-medical use of pharmaceuticals, commercial, and homemade drugs appear dependent on availability of opiates, prescribing practices, supervision of substitution drug dosing, availability of cheap ingredients, policing, and awareness of harms. Adverse health and social consequences relate to the use of unknown and contaminated (end) substances, injecting practices, redosing, medical complications, and death. The review highlights a public health imperative requiring a multidisciplinary approach to quantify potential impact and required integrated policy responses incorporating international regulation, enforcement, health surveillance and service delivery.
- Published
- 2014
- Full Text
- View/download PDF
48. Treatment of clinical Brachyspira hyodysenteriae with zinc chelate in pigs: a blinded, randomised controlled trial
- Author
-
Robbert van Berkel, Jobke van Hout, Gerwen Lammers, Henriëtte Brouwer-Middelesch, Daisy Roijackers, and Carly Vulders
- Subjects
medicine.medical_specialty ,General Veterinary ,040301 veterinary sciences ,medicine.drug_class ,business.industry ,Antibiotics ,0402 animal and dairy science ,04 agricultural and veterinary sciences ,General Medicine ,Placebo ,040201 dairy & animal science ,Feed conversion ratio ,Gastroenterology ,law.invention ,0403 veterinary science ,Clinical trial ,Antibiotic resistance ,Randomized controlled trial ,law ,Brachyspira hyodysenteriae ,Internal medicine ,medicine ,business ,Feces - Abstract
Background Brachyspira hyodysenteriae infection in pigs (‘swine dysentery’) leads to decreased feed conversion, growth losses and mortality. Current countermeasures have the downside of antibiotic resistance (antibiotics) and ecotoxicity (zinc oxide). The aim of this study was to evaluate the effect of a novel zinc chelate (Intra Dysovinol (ID)) on clinical signs of swine dysentery and shedding of B hyodysenteriae under field conditions. Methods In a randomised, double-blinded, controlled trial under Good Clinical Practice on two commercial farms, 58 B hyodysenteriae positive pigs from 16 pens received drinking water containing ID, or placebo, during six consecutive days. Faecal quality (consistency, colour, additions) was scored and faeces were analysed for presence of B hyodysenteriae by PCR. ID treatment positively affected faecal quality (consistency) and daily growth rates. Results At the last treatment day, B hyodysenteriae was not detectable in the faeces of any of the ID-treated animals, while all placebo animals remained B hyodysenteriae positive by PCR. All ID-treated animals recovered, while 5 placebo-treated animals died and 12 placebo pigs required additional treatment before the end of the study (up to 14 days after treatment start). Conclusion This non-antibiotic treatment stopped the clinical signs and shedding of B hyodysenteriae in naturally infected pigs.
- Published
- 2019
- Full Text
- View/download PDF
49. Variation of d′ estimates in two versions of the A-Not A task
- Author
-
Hautus, M. J., primary, van Hout, D., additional, Lee, H.-S., additional, Stocks, M. A., additional, and Shepherd, D., additional
- Published
- 2018
- Full Text
- View/download PDF
50. New mutations and an updated database for the patched-1 (PTCH1 ) gene
- Author
-
Reinders, Marie G., primary, van Hout, Antonius F., additional, Cosgun, Betûl, additional, Paulussen, Aimée D., additional, Leter, Edward M., additional, Steijlen, Peter M., additional, Mosterd, Klara, additional, van Geel, Michel, additional, and Gille, Johan J., additional
- Published
- 2018
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.